Wir sind mit live! Mehr erfahren

Paysign

PAYS

Börsenwert 836 Mio. $

14,80 USD

-0,80

5,13 %

Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT

Vor Börsenbeginn

Nachbörslich

14,42

-0,38

2,57 %

1 Tag

-5,13 %

5 Tage

-4,15 %

1 Monat

25,21 %

3 Monate

69,53 %

6 Monate

153,42 %

Seit Jahresbeginn

198,39 %

1 Jahr

168,12 %

5 Jahre

489,64 %

10 Jahre

301,08 %

Profil: PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The The company generates revenues from pharma card programs through card program management fees, transaction claim processing fees, interchange fees, customer service fees, other billable service fees and settlement income and other revenues are generated through cardholder fees, interchange fees, program management fees, load fees and breakage.

Mitarbeiter: 226

Technologie Software – Infrastruktur

Nachrichten

Positiv

Neutral

Negativ

Stimmung 3 Monate

Positiv 53,8 %

Neutral 38,5 %

Negativ 7,7 %

Investors Business Daily

Fintech Leader Vaults 203% To Highs: Earnings On Deck

Fintech stock Paysign scores a new high Friday with a year-to-date gain of 203%. Paysign provides finance tools for several industries.

Fintech Leader Vaults 203% To Highs: Earnings On Deck

Paysign to Host Third Quarter 2026 Earnings Call

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, will discuss third quarter 2026 earnings at 5:00 p.m. Eastern time on Monday, November 9, 2026. Participant details are as follows: U.S. dial-in: 877.407.2988 International dial-in: +1.201.389.0923 Webcast: Click Here Replay: Dial-in: 877.660.6853.

Paysign to Host Third Quarter 2026 Earnings Call

Beyond Bank Earnings: 4 Best Financial Stocks For Rising Rates

The best financial stocks to combat rising rates and inflation in Q4 may be those with superior growth and momentum, not traditional banks and brokerages. Persistent inflation and elevated interest rates raise the importance of finding companies capable of growing revenue and earnings despite tighter financial conditions. Consumer finance and digital payments offer secular growth opportunities as borrowing needs and increasingly digital financial behavior support demand.

Beyond Bank Earnings: 4 Best Financial Stocks For Rising Rates

Top Stocks Averaging 100% Forward EPS Growth To Combat AI Capex Fatigue

AI capex fatigue may encourage investors to broaden their search for fundamentally strong growth stocks beyond companies dependent on massive AI infrastructure spending. Strong forward EPS growth can identify companies whose improving fundamentals and operating leverage may support continued earnings expansion independent of AI spending. Diversifying exposure across consumer finance, healthcare payments, and health insurance can reduce reliance on the AI infrastructure investment cycle.

Top Stocks Averaging 100% Forward EPS Growth To Combat AI Capex Fatigue

Paysign Targets $117M Revenue as Patient-Affordability Business Surges

Paysign NASDAQ: PAYS operates in two healthcare-focused businesses: payment services for plasma donors and pharmaceutical patient-affordability programs, Chief Financial Officer Jeff Baker said during a company presentation.

Paysign Targets $117M Revenue as Patient-Affordability Business Surges

Zacks Investment Research

Paysign (PAYS) is an Incredible Growth Stock: 3 Reasons Why

Paysign (PAYS) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Paysign (PAYS) is an Incredible Growth Stock: 3 Reasons Why

Zacks Investment Research

Paysign (PAYS) Upgraded to Buy: What Does It Mean for the Stock?

Paysign (PAYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Paysign (PAYS) Upgraded to Buy: What Does It Mean for the Stock?

Paysign, Inc. to Present at the 17th Annual Midwest IDEAS Investor Conference

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced it will be presenting at the 17th Annual Midwest IDEAS Investor Conference to be held August 26-27, 2026 at the InterContinental in Chicago, Illinois. The conference is an annual invitation-only event, featuring quality public comp.

Paysign, Inc. to Present at the 17th Annual Midwest IDEAS Investor Conference

Zacks Investment Research

Are Business Services Stocks Lagging Paysign (PAYS) This Year?

Here is how Paysign, Inc. (PAYS) and Sezzle Inc. (SEZL) have performed compared to their sector so far this year.

Are Business Services Stocks Lagging Paysign (PAYS) This Year?

Zacks Investment Research

3 Reasons Growth Investors Will Love Paysign (PAYS)

Paysign (PAYS) is well positioned to outperform the market, as it exhibits above-average growth in financials.

3 Reasons Growth Investors Will Love Paysign (PAYS)

Nachrichtenrankings ansehen

Kursdiagramme mit Lightweight Charts™ umgesetzt